Angi A. Alwakeel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Angi A. Alwakeel has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed El-Assmy
Faculty of Medicine, Mansoura University, Egypt
2 shared publications Alaa M. Abdelkader
Mansoura University Children Hospital
1 shared publication- Ashraf Fouda
Mansoura University Children’s Hospital, Mansoura University
1 shared publication Gehan Attia
Mansoura University
1 shared publicationHanem M. El-Tahan
Mansoura University Children Hospital
1 shared publication- Magdy Zedan
Magdy Mohamed Zedan, Wafaa Nabil Laimon, Amal Mohamed Osman, Mohamed Magdy Zedan, Department of Asthma, Allergy and Immunology, Mansoura Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
1 shared publication
Latest Publications
- 2 February 2012
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 79 (9) , 1176-1180
Does Decline of Lung Function in Wheezy Infants Justify the Early Start of Controller Medications?
- 2 February 2012
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 79 (9) , 1176-1180
Does Decline of Lung Function in Wheezy Infants Justify the Early Start of Controller Medications?
- 10 September 2011
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 171 (2) , 383-388
Normal saline is a safe initial rehydration fluid in children with diarrhea-related hypernatremia
To demonstrate safety and efficacy of using normal saline (NS) for initial volume expansion (IVE) and rehydration in children with diarrhea-related hypernatremic dehydration (DR-HD), forty eight patients with DR-HD were retrospectively studied. NS was used as needed for IVE and for initial rehydration. Fluid deficit was given over 48 h. Median Na+ level on admission was 162.9 mEq/L (IQR 160.8–165.8). The median average hourly drop at 6 and 24 h was 0.53 mEq/L/h (0.48–0.59) and 0.52 mEq/L/h (0.47–0.57), respectively. Compared to children not needing IVE, receiving ≥40 ml/kg IVE was associated with a higher average hourly drop of Na+ at 6 h (0.51 vs. 0.58 mEq/L/h, p = 0.013) but not at 24 h (p = 0.663). The three patients (6.3%) with seizures had a higher average hourly drop of Na+ at 6 and 24 h (p = 0.084 and 0.021, respectively). Mortality (4/48, 8.3%) was not related to Na+ on admission or to its average hourly drop at 6 or 24 h. Children receiving ≥40 ml/kg IVE were more likely to die (OR 3.3; CI, 1.5–7.2). Conclusion: In children with DR-HD, NS is a safe rehydration fluid with a satisfactory rate of Na+ drop and relatively low incidence of morbidity and mortality. Judicious use of IVE should be exerted and closer monitoring should be guaranteed for children requiring large volumes for IVE and for those showing rapid initial drop of serum Na+ to avoid neurological complications and poor outcome.
- 10 September 2011
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 171 (2) , 383-388
Normal saline is a safe initial rehydration fluid in children with diarrhea-related hypernatremia
To demonstrate safety and efficacy of using normal saline (NS) for initial volume expansion (IVE) and rehydration in children with diarrhea-related hypernatremic dehydration (DR-HD), forty eight patients with DR-HD were retrospectively studied. NS was used as needed for IVE and for initial rehydration. Fluid deficit was given over 48 h. Median Na+ level on admission was 162.9 mEq/L (IQR 160.8–165.8). The median average hourly drop at 6 and 24 h was 0.53 mEq/L/h (0.48–0.59) and 0.52 mEq/L/h (0.47–0.57), respectively. Compared to children not needing IVE, receiving ≥40 ml/kg IVE was associated with a higher average hourly drop of Na+ at 6 h (0.51 vs. 0.58 mEq/L/h, p = 0.013) but not at 24 h (p = 0.663). The three patients (6.3%) with seizures had a higher average hourly drop of Na+ at 6 and 24 h (p = 0.084 and 0.021, respectively). Mortality (4/48, 8.3%) was not related to Na+ on admission or to its average hourly drop at 6 or 24 h. Children receiving ≥40 ml/kg IVE were more likely to die (OR 3.3; CI, 1.5–7.2). Conclusion: In children with DR-HD, NS is a safe rehydration fluid with a satisfactory rate of Na+ drop and relatively low incidence of morbidity and mortality. Judicious use of IVE should be exerted and closer monitoring should be guaranteed for children requiring large volumes for IVE and for those showing rapid initial drop of serum Na+ to avoid neurological complications and poor outcome.